Department of Urology, National Taiwan University Hospital, Taipei, Taiwan.
Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York.
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):317-325. doi: 10.1158/1055-9965.EPI-20-1090. Epub 2020 Dec 4.
Aristolochic acids (AA) and arsenic are chemical carcinogens associated with urothelial carcinogenesis. Here we investigate the combined effects of AA and arsenic toward the risk of developing upper tract urothelial carcinoma (UTUC).
Hospital-based ( = 89) and population-based (2,921 cases and 11,684 controls) Taiwanese UTUC cohorts were used to investigate the association between exposure to AA and/or arsenic and the risk of developing UTUC. In the hospital cohort, AA exposure was evaluated by measuring aristolactam-DNA adducts in the renal cortex and by identifying A>T mutations in tumors. In the population cohort, AA exposure was determined from prescription health insurance records. Arsenic levels were graded from 0 to 3 based on concentrations in well water and the presence of arseniasis-related diseases.
In the hospital cohort, 43, 26, and 20 patients resided in grade 0, 1+2, and 3 arseniasis-endemic areas, respectively. Aristolactam-DNA adducts were present in >90% of these patients, indicating widespread AA exposure. A>T mutations in were detected in 28%, 44%, and 22% of patients residing in grade 0, 1+2, and 3 arseniasis-endemic areas, respectively. Population studies revealed that individuals who consumed more AA-containing herbs had a higher risk of developing UTUC in both arseniasis-endemic and nonendemic areas. Logistic regression showed an additive effect of AA and arsenic exposure on the risk of developing UTUC.
Exposure to both AA and arsenic acts additively to increase the UTUC risk in Taiwan.
This is the first study to investigate the combined effect of AA and arsenic exposure on UTUC.
马兜铃酸(AA)和砷是与尿路上皮癌发生相关的化学致癌物质。在此,我们研究了 AA 和砷联合作用对发展为上尿路尿路上皮癌(UTUC)的风险。
我们使用基于医院的(=89)和基于人群的(2921 例病例和 11684 例对照)台湾 UTUC 队列来研究 AA 和/或砷暴露与发展为 UTUC 的风险之间的关联。在医院队列中,通过测量肾皮质中的马兜铃酸-DNA 加合物和鉴定肿瘤中的 A>T 突变来评估 AA 暴露。在人群队列中,通过处方健康保险记录确定 AA 暴露。根据井水浓度和是否存在砷相关疾病,将砷水平从 0 到 3 进行分级。
在医院队列中,分别有 43、26 和 20 名患者居住在砷疫区 0、1+2 和 3 级地区。>90%的患者存在马兜铃酸-DNA 加合物,表明广泛存在 AA 暴露。居住在砷疫区 0、1+2 和 3 级地区的患者中,分别有 28%、44%和 22%的患者存在 中的 A>T 突变。人群研究表明,在砷疫区和非疫区,摄入更多含有 AA 的草药的个体患 UTUC 的风险更高。Logistic 回归显示 AA 和砷暴露对发展为 UTUC 的风险具有相加效应。
暴露于 AA 和砷会协同作用,增加台湾 UTUC 的风险。
这是第一项研究 AA 和砷暴露联合作用对 UTUC 的影响的研究。